Myopia Prevention in Young Premyopic Children Using Defocus Incorporated Multiple Segments Spectacle Lenses
NCT: NCT07765550 · NOT_YET_RECRUITING
Brief Summary
Pre-myopia refers to a condition in which children have not yet developed myopia but exhibit insufficient hyperopic reserve (≤ +0.75 D). This is particularly relevant for young children aged 6 years and under; if their hyperopic reserve is depleted prematurely and they progress into the pre-myopia stage, the likelihood of developing myopia or even high myopia in the future becomes extremely high. Therefore, this study plans to conduct a parallel-design, open-label, single-center randomized controlled clinical trial to evaluate the efficacy and safety of artificial intelligence-assisted Defocus Incorporated Multiple Segments Triple Enhanced Design (AI-DIMS) spectacle lenses in preventing and controlling myopia in pre-myopic children aged 3 to 6 years.
Frequently Asked Questions
What is Myopia Prevention in Young Premyopic Children Using Defocus Incorporated Multiple Segments Spectacle Lenses?
Myopia Prevention in Young Premyopic Children Using Defocus Incorporated Multiple Segments Spectacle Lenses is a clinical trial registered under NCT07765550. Current status: NOT_YET_RECRUITING.
What is the status of NCT07765550?
The current status of NCT07765550 (Myopia Prevention in Young Premyopic Children Using Defocus Incorporated Multiple Segments Spectacle Lenses) is: NOT_YET_RECRUITING.
When did Myopia Prevention in Young Premyopic Children Using Defocus Incorporated Multiple Segments Spectacle Lenses start?
Myopia Prevention in Young Premyopic Children Using Defocus Incorporated Multiple Segments Spectacle Lenses started on 2026-09-12.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.